OTCMKTS:APNHY Aspen Pharmacare (APNHY) Stock Price, News & Analysis $9.52 0.00 (0.00%) As of 10/2/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartDividendNews and TrendsShort Interest About Aspen Pharmacare Stock (OTCMKTS:APNHY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Aspen Pharmacare alerts:Sign Up Key Stats Today's Range$9.52▼$9.5250-Day Range$8.61▼$10.0552-Week Range$5.24▼$10.05Volume6 shsAverage Volume1,444 shsMarket Capitalization$4.12 billionP/E RatioN/ADividend Yield0.84%Price TargetN/AConsensus RatingN/A Company Overview Aspen Pharmacare Holdings Limited is a South African multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997, the company develops, manufactures and supplies branded and generic medicines, consumer health products, and pharmaceutical ingredients. Aspen operates across several pharmaceutical categories, including prescription medicines, over-the-counter products, hospital medicines, anesthetics, and sterile injectable products. Its manufacturing capabilities also include vaccines and other complex pharmaceutical formulations, supporting supply to healthcare providers, governments and pharmaceutical partners. The company serves markets in Africa and internationally, with operations and commercial activities spanning Europe, the Americas, Asia and Australia. Aspen Pharmacare is led by Group Chief Executive Stephen Saad and has built its business through organic growth, acquisitions and partnerships with other pharmaceutical companies.AI Generated. May Contain Errors. Read More Receive APNHY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aspen Pharmacare and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. APNHY Stock News HeadlinesAspen Pharmacare Earnings Call Signals Cash-Fueled ComebackSeptember 15, 2026 | tipranks.comAspen Pharmacare Holdings Ltd ADR APNHYSeptember 3, 2026 | morningstar.comMTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.October 4 at 1:00 AM | Porter & Company (Ad)Aspen Pharmacare Holdings Limited (APNHY) Q4 2026 Earnings Call TranscriptSeptember 3, 2026 | seekingalpha.comMerck signs licensing deals with companies including Viatris for new HIV pillJuly 24, 2026 | seekingalpha.comAspen Joins Africa Push to Make MSD’s HIV Prevention PillJuly 24, 2026 | financialpost.comFAspen Pharmacare Holdings Limited (APNHY) Shareholder/Analyst Call Prepared Remarks TranscriptMay 29, 2026 | seekingalpha.comAspen Pharmacare Holdings Insider Ups Holding During YearApril 3, 2026 | finance.yahoo.comSee More Headlines APNHY Stock Analysis - Frequently Asked Questions How have APNHY shares performed this year? Aspen Pharmacare's stock was trading at $6.5848 at the beginning of the year. Since then, APNHY stock has increased by 44.6% and is now trading at $9.5230. How do I buy shares of Aspen Pharmacare? Shares of APNHY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/04/2026Fiscal Year End6/30/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:APNHY Previous SymbolNASDAQ:APNHY CIK1454177 Webwww.aspenpharma.com Phone(731) 580-8600Fax27-11-239-6144Employees9,557Year Founded1850Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.12 Current Ratio2.54 Quick Ratio1.68 Sales & Book Value Annual Sales$2.07 billion Price / Sales2.00 Cash Flow$0.91 per share Price / Cash Flow10.45 Book Value$10.66 per share Price / Book0.89Miscellaneous Outstanding Shares432,921,000Free FloatN/AMarket Cap$4.12 billion OptionableNot Optionable Beta0.75 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:APNHY) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredHow Elon’s Empire Ends (and how to profit)Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredWATCH THIS BEFORE DECEMBER 8th!!James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has...Paradigm Press | SponsoredA major gold reset could be closer than people thinkFor 50 years, Washington has held 8,133 tonnes of gold on its books at a fraction of today's market price. One...Reagan Gold Group | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | SponsoredA new kind of civil war is coming after election day?Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the politic...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspen Pharmacare Please log in to your account or sign up in order to add this asset to your watchlist. Share Aspen Pharmacare With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
